These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33693305)

  • 1. (Ultra-)low dosing of rituximab in rheumatoid arthritis: chances and challenges.
    den Broeder AA; den Broeder N; Verhoef LM
    Rheumatol Adv Pract; 2021; 5(1):rkab007. PubMed ID: 33693305
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial.
    den Broeder AA; Verhoef LM; Fransen J; Thurlings R; van den Bemt BJF; Teerenstra S; Boers N; den Broeder N; van den Hoogen FHJ
    Trials; 2017 Aug; 18(1):403. PubMed ID: 28854956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rituximab in patients with rheumatoid arthritis: systematic review].
    Brodszky V; Czirják L; Géher P; Hodinka L; Kárpáti K; Péntek M; Poór G; Szekanecz Z; Gulácsi L
    Orv Hetil; 2007 Oct; 148(40):1883-93. PubMed ID: 17905683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of rituximab (anti-CD20 monoclonal antibody) in rheumatoid arthritis patients during a phase II clinical trial.
    Ng CM; Bruno R; Combs D; Davies B
    J Clin Pharmacol; 2005 Jul; 45(7):792-801. PubMed ID: 15951469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series.
    Lobbes H; Dervout C; Toussirot E; Felten R; Sibilia J; Wendling D; Gombert B; Ruivard M; Grobost V; Saraux A; Cornec D; Verhoeven F; Soubrier M
    Semin Arthritis Rheum; 2020 Oct; 50(5):1109-1113. PubMed ID: 32920324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe infection in patients with rheumatoid arthritis taking anakinra, rituximab, or abatacept: a systematic review of observational studies.
    Cabral VP; Andrade CA; Passos SR; Martins MF; Hökerberg YH
    Rev Bras Reumatol Engl Ed; 2016; 56(6):543-550. PubMed ID: 27914602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as a treatment option in a patient with rheumatoid arthritis and a history of malignancy-intracranial chondrosarcoma/osteochondroma-case based review.
    Barešić M; Ježić I; Simetić L; Herceg D; Anić B
    Rheumatol Int; 2021 Feb; 41(2):463-468. PubMed ID: 33001390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive review of rituximab therapy in rheumatoid arthritis patients.
    Tavakolpour S; Alesaeidi S; Darvishi M; GhasemiAdl M; Darabi-Monadi S; Akhlaghdoust M; Elikaei Behjati S; Jafarieh A
    Clin Rheumatol; 2019 Nov; 38(11):2977-2994. PubMed ID: 31367943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.
    Brown S; Everett CC; Naraghi K; Davies C; Dawkins B; Hulme C; McCabe C; Pavitt S; Emery P; Sharples L; Buch MH
    Health Technol Assess; 2018 Jun; 22(34):1-280. PubMed ID: 29900829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of acute HVE infection in a patient treated with rituximab for rheumatoid arthritis.
    Verhoeven F; Weil-Verhoeven D; Di Martino V; Prati C; Thevenot T; Wendling D
    Joint Bone Spine; 2016 Oct; 83(5):577-8. PubMed ID: 27055728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study.
    Gerlag DM; Safy M; Maijer KI; Tang MW; Tas SW; Starmans-Kool MJF; van Tubergen A; Janssen M; de Hair M; Hansson M; de Vries N; Zwinderman AH; Tak PP
    Ann Rheum Dis; 2019 Feb; 78(2):179-185. PubMed ID: 30504445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunologic predictors of effect of anti-B-cell therapy under rheumatoid arthritis].
    Avdeeva AS; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
    Klin Lab Diagn; 2014 Mar; (3):48-52. PubMed ID: 25080789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
    Wijesinghe H; Galappatthy P; de Silva R; Seneviratne SL; Saravanamuttu U; Udagama P; Hart M; Kelleher P; Senerath U; Fernandopulle R; Weerasekera LP; Wijayaratne LS
    BMC Musculoskelet Disord; 2017 Jul; 18(1):310. PubMed ID: 28724365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid meningitis as a complication of long-standing rheumatoid arthritis: a case treated with rituximab.
    Del Bosque Granero I; Loarce-Martos J; Blázquez Cañamero MÁ; Buisan Catevilla FJ; Medina Díaz M; Bachiller-Corral FJ
    Mod Rheumatol Case Rep; 2021 Jul; 5(2):200-205. PubMed ID: 33336629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study.
    Gottenberg JE; Morel J; Perrodeau E; Bardin T; Combe B; Dougados M; Flipo RM; Saraux A; Schaeverbeke T; Sibilia J; Soubrier M; Vittecoq O; Baron G; Constantin A; Ravaud P; Mariette X;
    BMJ; 2019 Jan; 364():l67. PubMed ID: 30679233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.
    Lavielle M; Mulleman D; Goupille P; Bahuaud C; Sung HC; Watier H; Thibault G
    Arthritis Res Ther; 2016 Oct; 18(1):253. PubMed ID: 27793209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab as first choice for patients with refractory rheumatoid arthritis: cost-effectiveness analysis in Iran based on a systematic review and meta-analysis.
    Ahmadiani S; Nikfar S; Karimi S; Jamshidi AR; Akbari-Sari A; Kebriaeezadeh A
    Rheumatol Int; 2016 Sep; 36(9):1291-300. PubMed ID: 27136919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure.
    Kekow J; Mueller-Ladner U; Schulze-Koops H
    Biologics; 2012; 6():191-9. PubMed ID: 22848150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis.
    Tran L; Huitema AD; van Rijswijk MH; Dinant HJ; Baars JW; Beijnen JH; Vogel WV
    Hum Antibodies; 2011; 20(1-2):29-35. PubMed ID: 21558621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The long-term remission of rheumatoid arthritis with a single cycle of rituximab].
    Glisić B; Knezević B
    Vojnosanit Pregl; 2012 Jan; 69(1):78-80. PubMed ID: 22397300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.